Opportunity Information: Apply for HRSA 14 049
Apply for HRSA 14 049
- The Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.917 HIV Care Formula Grants.
- This funding opportunity was created on Oct 11, 2013 and posted on Oct 10, 2013.
- Applicants must submit their applications by Nov 25, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $75,000,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 59 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) State governments.
- States that reported an ADAP waiting list and/or cost containment measures to HRSA since calendar year 2011 are eligible to apply for Limited New Competitive ADAP ERF Awards. All 50 States, the District of Columbia, the Commonwealth of Puerto Rico, and the U.S. Virgin Islands are eligible to apply for funding if they meet the above requirement
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF) opportunity (HRSA-14-049) is a discretionary grant competition run by the U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA), through its HIV/AIDS Bureau (HAB) and the Division of State HIV/AIDS Programs. It sits under the Ryan White HIV/AIDS Program Part B and is designed as an emergency funding tool that allows the Secretary to direct resources to help control disease epidemics. In practical terms, this funding is aimed at strengthening state and territorial ADAP programs when they are under acute strain, especially when people are being placed on ADAP waiting lists or when aggressive cost containment is needed to keep the program viable and prevent waiting lists from forming.
The core purpose of these limited new competing ADAP ERF awards is to provide additional resources to States and Territories that can clearly demonstrate they need extra funding to prevent, reduce, or eliminate ADAP waiting lists, or to implement cost cutting and cost saving steps that stabilize the program. HRSA emphasizes that awards are not automatic; applicants are expected to make a convincing case for need and to show that they have already taken meaningful steps to improve the cost effectiveness of ADAP operations in line with HRSA policies and recommendations. Applications are reviewed and scored by an external Objective Review Committee (ORC) using criteria published in the funding opportunity announcement, and the competition gives priority to proposals that address waiting lists.
A key program rule drives how awarded funds must be used, depending on a jurisdiction's situation. If a State or Territory has an ADAP waiting list that was reported to HRSA, then all funding awarded under this announcement must be used specifically to remove clients from that waiting list. If a State did not report a waiting list, then the funds must be used to address cost cutting measures and/or to support implementation of cost saving measures during the project period to prevent a waiting list from developing. The announcement provides examples of cost cutting pressures the funding can help address, such as situations where a state has reduced ADAP eligibility below 300 percent of the Federal Poverty Level (FPL) and/or reduced the formulary, including antiretroviral drugs and medications used to treat opportunistic infections or HIV/AIDS complications. In other words, the funding is tightly tied to either directly clearing a backlog of clients waiting for medication assistance or shoring up program financing so access does not collapse into a waiting list.
Eligibility is limited to government entities running ADAP at the State or Territory level. Specifically, States that have reported an ADAP waiting list and/or cost containment measures to HRSA at any point since calendar year 2011 are eligible to apply for these limited new competitive awards. The eligible jurisdictions include all 50 States, the District of Columbia, the Commonwealth of Puerto Rico, and the U.S. Virgin Islands, as long as they meet the reporting-related eligibility requirement. There is no cost sharing or matching requirement listed for this opportunity, which means applicants are not required to contribute non-federal funds as a condition of award.
From a funding and administrative standpoint, the opportunity was posted on October 10, 2013 (created October 11, 2013), with an application closing date of November 25, 2013, and an archive date of January 24, 2014. HRSA anticipated up to 59 awards and listed an estimated total funding amount of $75,000,000. The CFDA number associated with this opportunity is 93.917 (HIV Care Formula Grants). The listing shows an award ceiling and floor of 0, which typically indicates that specific per-award amounts were not pre-set in the summary and would instead be determined based on need, availability of funds, and application scores.
For applicants needing help accessing the full announcement or navigating submission issues, HRSA directed inquiries to the HRSA Grants Application Center in Gaithersburg, Maryland, and to the HRSA Call Center (877-464-4772) or CallCenter@HRSA.GOV.
Frequently Asked Questions (FAQs): ADAP Emergency Relief Funds (ERF) - HRSA-14-049
What is the ADAP Emergency Relief Funds (ERF) opportunity (HRSA-14-049)?
The AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF) opportunity (HRSA-14-049) is a discretionary grant competition run by the U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA), through HRSA's HIV/AIDS Bureau (HAB) and the Division of State HIV/AIDS Programs.
What program does this funding fall under?
This opportunity sits under the Ryan White HIV/AIDS Program Part B and is intended to strengthen State and Territorial ADAP programs during periods of acute strain.
What is the main purpose of ADAP ERF awards?
The core purpose of these limited new competing awards is to provide additional resources to States and Territories that can demonstrate a need for extra funding to prevent, reduce, or eliminate ADAP waiting lists, or to implement cost cutting and cost saving steps that stabilize the ADAP program.
Is this funding intended to respond to emergencies?
Yes. The ERF mechanism is described as an emergency funding tool that allows the Secretary to direct resources to help control disease epidemics. Practically, the funds are targeted to situations where ADAP programs are under acute strain (for example, when waiting lists exist or when aggressive cost containment is required to keep the program viable).
Are awards automatic for eligible jurisdictions?
No. HRSA emphasizes that awards are not automatic. Applicants are expected to make a convincing case for need and show that they have already taken meaningful steps to improve the cost effectiveness of ADAP operations in line with HRSA policies and recommendations.
How are applications reviewed and selected?
Applications are reviewed and scored by an external Objective Review Committee (ORC) using criteria published in the funding opportunity announcement.
Does the competition prioritize any particular type of proposal?
Yes. The competition gives priority to proposals that address ADAP waiting lists.
How must awarded funds be used if a State or Territory has an ADAP waiting list?
If a State or Territory has an ADAP waiting list that was reported to HRSA, then all funding awarded under this announcement must be used specifically to remove clients from that waiting list.
How must awarded funds be used if a State or Territory did not report an ADAP waiting list?
If a State did not report a waiting list, then funds must be used to address cost cutting measures and/or to support implementation of cost saving measures during the project period to prevent a waiting list from developing.
What kinds of program pressures can these funds help address?
The announcement provides examples of cost cutting pressures this funding can help address, including situations where a State has reduced ADAP eligibility below 300 percent of the Federal Poverty Level (FPL) and/or reduced the formulary (including antiretroviral drugs and medications used to treat opportunistic infections or HIV/AIDS complications).
Who is eligible to apply for this opportunity?
Eligibility is limited to government entities running ADAP at the State or Territory level.
What specific eligibility condition is tied to reporting to HRSA?
States that have reported an ADAP waiting list and/or cost containment measures to HRSA at any point since calendar year 2011 are eligible to apply for these limited new competitive awards.
Which jurisdictions are included as potentially eligible?
The eligible jurisdictions include all 50 States, the District of Columbia, the Commonwealth of Puerto Rico, and the U.S. Virgin Islands, as long as they meet the reporting-related eligibility requirement.
Is there a cost sharing or matching requirement?
No cost sharing or matching requirement is listed for this opportunity, meaning applicants are not required to contribute non-federal funds as a condition of award.
When was this funding opportunity posted and when was the application due?
The opportunity was posted on October 10, 2013 (created October 11, 2013). The application closing date was November 25, 2013.
When was this opportunity archived?
The archive date listed for this opportunity is January 24, 2014.
How many awards did HRSA anticipate making?
HRSA anticipated up to 59 awards.
What was the estimated total funding amount?
The estimated total program funding amount listed is $75,000,000.
What is the CFDA number associated with this opportunity?
The CFDA number associated with this opportunity is 93.917 (HIV Care Formula Grants).
Were minimum or maximum award amounts specified in the summary?
The listing shows an award ceiling and floor of 0, which typically indicates that specific per-award amounts were not pre-set in the summary and would be determined based on need, availability of funds, and application scores.
What HRSA offices are associated with administering this opportunity?
This competition is run by HRSA through the HIV/AIDS Bureau (HAB) and the Division of State HIV/AIDS Programs.
Where can applicants get help with accessing the announcement or submission issues?
HRSA directed inquiries to the HRSA Grants Application Center in Gaithersburg, Maryland, and to the HRSA Call Center at (877) 464-4772 or by email at CallCenter@HRSA.GOV.
What is the practical goal of tying funds to waiting lists or cost saving measures?
The practical goal is to ensure funds are tightly directed either to removing clients from a reported ADAP waiting list or to stabilizing program financing through cost cutting and cost saving steps so that access does not deteriorate into a waiting list.
Browse more opportunities from the same category: Health
Next opportunity: MEASURE Evaluation Phase IV
Previous opportunity: DoD Breast Cancer Postdoctoral Fellowship Award
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HRSA 14 049
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (HRSA 14 049) also looked into and applied for these:
| Funding Opportunity |
|---|
| MEASURE Evaluation Phase IV Apply for SOL OAA 14 000005 Funding Number: SOL OAA 14 000005 Agency: Agency for International Development Category: Health Funding Amount: $181,000,000 |
| NIBIB Biomedical Technology Resource Centers (P41) Apply for PAR 13 376 Funding Number: PAR 13 376 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U01) Apply for RFA TR 13 003 Funding Number: RFA TR 13 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Basic Research in the Pathogenesis of HIV Related Heart, Lung, and Blood (HLB) Diseases in Adults and Children (R21) Apply for RFA HL 14 029 Funding Number: RFA HL 14 029 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Basic Research in the Pathogenesis of HIV Related Heart, Lung, and Blood (HLB) Diseases in Adults and Children (R01) Apply for RFA HL 14 024 Funding Number: RFA HL 14 024 Agency: National Institutes of Health Category: Health Funding Amount: $499,999 |
| Establishing Outcome Measures for Clinical Studies of Oral and Craniofacial Diseases and Conditions (R21) Apply for PAR 13 380 Funding Number: PAR 13 380 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Establishing Outcome Measures for Clinical Studies of Oral and Craniofacial Diseases and Conditions (R01) Apply for PAR 13 379 Funding Number: PAR 13 379 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Service Area Competition Additional Area (SAC AA) Marquette, Michigan Omaha, Nebraska and Hood River, Oregon Apply for HRSA 14 108 Funding Number: HRSA 14 108 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Secondary Analyses of Social and Behavioral Datasets in Aging (R03) Apply for RFA AG 14 008 Funding Number: RFA AG 14 008 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Clinical Research in the Prevention, Diagnosis, and Treatment of HIV Related Heart, Lung, and Blood (HLB) Diseases in Adults and Children (R01) Apply for RFA HL 14 023 Funding Number: RFA HL 14 023 Agency: National Institutes of Health Category: Health Funding Amount: $499,999 |
| Pilot Clinical Trials to Eliminate the Latent HIV Reservoir (U01) Apply for RFA AI 13 055 Funding Number: RFA AI 13 055 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| FY14 Region 5 Ohio(Athens, Crawford, DelawareFranklin, Hocking, Lucas, Madison, Mahoning, Marion, Medina, Pickaway, Portage, Richland, Stark, Summit, Trumbull, Union and Wayne counties )Announcement of Anticipated Availability of Funds for Family Apply for PA FPH 14 033 Funding Number: PA FPH 14 033 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $2,924,926 |
| FY14 Region 6 Louisiana(entire state)Announcement of Anticipated Availability of Funds for Family Planning Services Grants Apply for PA FPH 14 034 Funding Number: PA FPH 14 034 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $4,745,826 |
| Reducing Loss to Follow up after Failure to Pass Newborn Hearing Screening Apply for HRSA 14 006 Funding Number: HRSA 14 006 Agency: Health Resources and Services Administration Category: Health Funding Amount: $250,000 |
| Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during the Influenza Season Apply for RFA IP 14 001 Funding Number: RFA IP 14 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Affordable Care Act Teaching Health Center Graduate Medical Education (THCGME) Program Apply for HRSA 14 060 Funding Number: HRSA 14 060 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Primary Care Services Resources Coordination and Development Apply for HRSA 14 001 Funding Number: HRSA 14 001 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Blood and Vascular Systems Response to Sepsis (R01) Apply for RFA HL 14 028 Funding Number: RFA HL 14 028 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| STD/HIV Disease Intervention Services Training Centers (DISTC) Apply for CDC RFA PS14 1408 Funding Number: CDC RFA PS14 1408 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| HIV Early Intervention Services (EIS Program) Existing Geographic Service Areas (EISEGA) Apply for HRSA 14 059 Funding Number: HRSA 14 059 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HRSA 14 049", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.